The table below shows Biohaven Ltd.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$609.44M
-$582.45M
-$331.73M
-$297.69M
-$145.84M
-$75.96M
Capital expenditure
$715.00K
$4.05M
$3.05M
$6.07M
$938.00K
$1.10M
Investing cash flow
$300.56M
-$244.97M
$129.83M
-$304.79M
$944.00K
-$2.70M
Dividends paid
-
-
-
-
-
BHVN operating cash flow (10-K history)
Biohaven Ltd. reported operating cash flow of -$609.44M for fiscal year 2025. That is down 4.6% from -$582.45M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$75.96M (FY 2020) to -$609.44M. Figures come from the company's audited annual reports as filed with the SEC.
